Coronary artery disease (CAD) patients in northern Nevada now have a new treatment option that literally disappears over time. Carson Tahoe Health is among the first in the country – and the only provider in the region – to offer the latest generation of the cardiology technology, Absorb.
The revolutionary Absorb bioresorbable, or naturally dissolving, vascular scaffold is a significant advancement in the treatment of CAD, which affects 15 million Americans and remains the leading cause of death worldwide. Physicians at Carson Tahoe Health successfully placed the Absorb stent for the first time earlier this month and are looking forward to changing lives with this technology.
“Absorb is a game-changing therapy for coronary artery disease,” said Michelle Joy, Vice President and Chief Operating Officer of Carson Tahoe Health. “This innovative technology provides the ability to repair a patient’s artery while reducing long-term complications. This method encourages healing while promoting and supporting the natural functions of the heart.”
Traditionally, metal stents have served as permanent implants, and been a patient’s only treatment option. Absorb is made of naturally dissolving materials, similar to dissolving sutures. Like metallic drug-eluding stents, Absorb opens and treats a patient’s blocked artery, but then fully dissolves after about three years, leaving no metal behind. The restored artery can flex and pulse naturally, promoting proper healing and reducing the risk of future blockages. Absorb can also make it easier for doctors to perform additional interventions in the case of another cardiac event.
“We are very excited to be the first ones to offer this leading-edge Absorb therapy – one of the world’s most advanced cardiac treatments – in northern Nevada” added Joy.
For details, visit www.carsontahoe.com/absorb.
[clickToTweet tweet=”Carson Tahoe Health First in Region to Offer Dissolving Heart Stent” quote=”Carson Tahoe Health First in Region to Offer Dissolving Heart Stent”]
